Pharmaceutical Executive September 19, 2025
Key Takeaways
- Merck’s use of deep data and AI has streamlined KOL identification, enhancing MSL productivity and engagement planning in new therapeutic areas.
- Real-time data access enables MSLs to customize engagements, improving efficiency and effectiveness in scientific interactions.
- AI integration allows for advanced analytics, combining quantitative and qualitative data to enhance the value story of medical affairs.
- Strategic engagement planning across functions is now more efficient, supporting pre-launch activities and congress participation.
- Success is defined by aligning innovations with medical and company goals, reducing administrative burdens, and ensuring scalability for future growth.
Merck’s executive director, operations lead, global medical affairs and outcomes research discusses how data is helping to identify scientific leaders.
Pharmaceutical Executive: How has Merck been...
Today's Sponsors
Today's Sponsor